Implications of Sarcopenia and Glucometabolism Parameters of Muscle Derived From Baseline and End-of-Treatment <sup>18</sup>F-FDG PET/CT in Diffuse Large B-Cell Lymphoma-Reference-Cited by-同舟云学术

Implications of Sarcopenia and Glucometabolism Parameters of Muscle Derived From Baseline and End-of-Treatment ¹⁸F-FDG PET/CT in Diffuse Large B-Cell Lymphoma

Published:2024 Issue:3 Volume:25 Page:277
ISSN:1229-6929
Container-title:Korean Journal of Radiology
language:en
Short-container-title:Korean J Radiol

Author:

Tan Xiaoyue¹,Sun Xiaolin¹,Chen Yang¹,Wang Fanghu¹,Shang Yuxiang¹,Zhang Qing¹,Yuan Hui¹^ORCID,Jiang Lei¹²^ORCID

Affiliation:

1. PET Center, Department of Nuclear Medicine, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.

2. Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangzhou, China.

Funder

National Natural Science Foundation of China

Guangdong Provincial People’s Hospital

Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application

Publisher

XMLink

Link

https://kjronline.org/pdf/10.3348/kjr.2023.0949

Reference32 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. 2021 Update on Diffuse large B cell lymphoma: A review of current data and potential applications on risk stratification and management

3. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

4. Sarcopenia: revised European consensus on definition and diagnosis

5. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sarcopenia is a prognostic factor in lymphoma patients: a systematic review and meta-analysis;Leukemia & Lymphoma;2024-07-31